CHINESE BIOPHARMACEUTICAL ASSOCIATION USA (EIN 752996955) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2001

Legal Domicile

Tax Period

2023-01-01 to 2023-12-31

CHINESE BIOPHARMACEUTICAL ASSOCIATION USA, founded in 2001, is a small nonprofit in the Medical Research sector that reported $123K in total revenue in fiscal year 2023. Revenue surged 81% from the prior year, signaling strong growth momentum. Expenses of $141K exceeded revenue, resulting in a 15% operating deficit.

Mission

HOLD CONFERENCES, MEETINGS, WORKSHOPS, AND ACTIVITIES TO FACILITATE COLLABORATION AMONG SCIENTISTS, ENGINEERS AND OTHER RELATED PROFESSIONALS IN BIOPHARMACEUTICAL FIELD

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $123,086

Program Service Revenue $0

Investment Income $208

Other Revenue $0

TOTAL REVENUE $123,294

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $123,786

Other Expenses $141,241

TOTAL EXPENSES $141,241

Year-over-Year Comparison

	2023	2022	Change
Revenue	$123,294	$68,050	+0.8%
Expenses	$141,241	$82,255	+0.7%
Net Income	$-17,947	$-14,205	+0.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
You Li	Director	1.00	Director	$0	$0	$0
Steve Chen	Director	1.00	Director	$0	$0	$0
Li Li	Director	1.00	Director	$0	$0	$0
Monica Zhang	Director	1.00	Director	$0	$0	$0
Hao Li	Director	1.00	Director	$0	$0	$0
Qi Zeng	Director	1.00	Director	$0	$0	$0
Angela Men	Director	1.00	Director	$0	$0	$0
Chuanhua Xing	Director	1.00	Director	$0	$0	$0
Dong Shen	Director	1.00	Director	$0	$0	$0
Harry Yang	Director	1.00	Director	$0	$0	$0
Qing Li	Director	1.00	Director	$0	$0	$0
Song Wu	Director	1.00	Director	$0	$0	$0
Jingyu Luan	Director	1.00	Director	$0	$0	$0
Yuling Wu	Director	1.00	Director	$0	$0	$0
Hang Lu	Director	1.00	Director	$0	$0	$0
Xiaobin Lu	Director	1.00	Director	$0	$0	$0
Xu-Rong Jiang	Director	1.00	Director	$0	$0	$0
Yali Fu	Director	1.00	Director	$0	$0	$0
Shoupeng Lai	Director	1.00	Director	$0	$0	$0
Edward Wang	Director	1.00	Director	$0	$0	$0
Ping Chen	Director	1.00	Director	$0	$0	$0
Richard Zhao	Director	1.00	Director	$0	$0	$0
Shou-Bai Chao	Director	1.00	Director	$0	$0	$0
Qiao Yu	Director	1.00	Director	$0	$0	$0
Alex Lai	Director	1.00	Director	$0	$0	$0
Ziping Wei	Director	1.00	Director	$0	$0	$0
Helen Mao	Director	1.00	Director	$0	$0	$0
Yingxian Xiao	Director	1.00	Director	$0	$0	$0
Zhifeng Long	Director	1.00	Director	$0	$0	$0
FEIYAN JIN	Treasurer	0.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$123,294	$141,241	$681,505	$-17,947
2022	$68,050	$82,255	$699,452	$-14,205
2021	$140,026	$31,264	$713,657	$108,762
2020	$40,416	$62,410	$604,895	$-21,994
2019	$590,604	$212,362	$626,889	$378,242

CHINESE BIOPHARMACEUTICAL ASSOCIATION USA